Cargando…
CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies
The substantial advances attained by checkpoint blockade immunotherapies have driven an expansion in the approaches used to promote T cell access to the tumor microenvironment to provide targets for checkpoint immunotherapy. Inherent in any T cell response to a tumor antigen is the capacity of dendr...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752810/ https://www.ncbi.nlm.nih.gov/pubmed/34282297 http://dx.doi.org/10.1038/s41423-021-00734-4 |